CANNAINVESTOR Magazine January / February 2017 - Page 97

He is also CEO of INTIVA Inc., a multi-faceted company in the worldwide legal cannabis industry. INTIVA has established operating businesses and made venture investments in the cannabis industry in California, Colorado, and Canada. INTIVA’s primary focus is the leasing of proprietary CO2 supercritical extraction systems to cannabis growers, extractors and edible products manufacturers; and the formulation and manufacturing of proprietary products that include the non-psychoactive cannabinoid, CBD. INTIVA also has investments in two Canadian cannabis growers licensed as “Licensed Producers” under Canada Health Canada regulations.

Mr. Friedland is a founder of Israel-based, Israel Plant Sciences Ltd., a company that is participating in Israel’s innovative agriculture and medicinal plant sectors and other agricultural related technologies, with an initial focus on medical cannabis.

He is also a board member of Israel-based CannRX, a company focused on the development of cannabis-based pharmaceuticals in Israel; and Kanna Enterprises, a product development, marketing and distribution company whose primary product is CanaGel a unique hemp/CBD oral delivery gel which utilizes a patented delivery system.

Jeffrey Friedland is also the CEO of the financial services firm Friedland Global Capital. Since 1979 the firm has provided corporate finance and strategic advisory services to entrepreneurial companies in emerging markets and assists companies with non-US stock market listings with the establishment of depositary receipt (DR) programs in the United States. The firm has been active in countries including China, Hong Kong, Sri Lanka, Indonesia and Brazil.

139

CANNA

INVESTOR

Webcast

45-minute live presentations and Q&A by CEOs, CFOs, and IROs of publicly-traded and privately-held cannabis companies. Visit cannawebcast.com

to register for live presentations!

Monthly Webcast

For replay visit our YOUTUBE Channel!

97